Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone now assessing Lp(a) in our patients????? @VietHeartPA @ASPCardio @CBallantyneMD @TheFHFoundation @rblument1 @DrM_ODonoghue
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2024 – Aug 2025Where it's discussed
-
X / Twitter119 posts
-
News48 articles
-
YouTube3 videos
-
Blogs2 articles
AI synopsis
What people are saying
The discussions consistently praise the study’s evidence that Lipoprotein(a) is significantly more atherogenic than LDL, with phrases like '6 times more atherogenic' and calls for universal testing to assess risk, driven by the substantial implications for cardiovascular disease prevention and personalized medicine; the tone is optimistic and urgent, emphasizing the need for clinical action.
Most discussions strongly support the study’s findings, emphasizing the heightened risk posed by Lipoprotein(a), with phrases like 'really this original research,' 'key target for drug intervention,' and '6x more atherogenic' indicating agreement with its
The posts demonstrate high interest by sharing detailed summaries, emphasizing the significance of the research, and encouraging testing and awareness, as seen in phrases like 'Do you know your Lp(a)?' and 'Why we shouldn’t be satisfied with just LDL targ
Many comments reference specific findings, use technical language about genetic analysis, and retweet important points, reflecting deep engagement with the research and its implications.
The discussions highlight the potential for increased clinical focus on Lp(a), framing it as a game changer for cardiovascular prevention, with posts calling for universal testing and changes in treatment approaches, indicating high perceived impact.
Abstract in brief
- Lipoprotein(a) (Lpa) is much more likely to cause coronary heart disease (CHD) than LDL, even when comparing individual particles, indicating higher atherogenicity.
- Genetic studies using the UK Biobank show that variations in Lpa significantly increase CHD risk more than similar changes in LDL, supporting its stronger role in disease development.
- The findings suggest that Lpa is about 6 times more atherogenic per particle than LDL, making it an important target for treatments to prevent CHD in at-risk populations.
Top posts
Most liked on X and BlueskyLipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College of Cardiology https://t.co/MrTdRIDSN3 @MAROSFO @almucastro01 @lipidmir https://t.co/ASmUg7cLzE
Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was roughly 6 times more atherogenic than LDL per particle. Read more from this important work: https://t.co/Y2GCIX4Fqf #JACC #cvPrev @stevesphd @EliasBjornson https://t.co/VC5bB4mUY3
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs https://t.co/NEOwim2WrX
On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Genetic Analysis Do you know your Lp(a)? I do ... https://t.co/E2TVwcWRK0
☑️ Lp(a)について Lp(a)「える・ぴー・りとるえー」は動脈硬化の原因で 1分子あたりの催動脈硬化作用はLDLの6倍程度
All mentions
Lipoprotein a: A More Dangerous Cholesterol than LDL
Lipoprotein a significantly increases the risk of heart disease compared to LDL, being about six times more atherogenic per particle. Recent genetic studies highlight its importance as a target for prevention and…
Understanding Lp(a): A Key Risk Factor in Cardiovascular Disease
Have you heard of Lp(a) and its impact on cardiovascular health? High levels of lipoprotein(a) are a significant, genetically determined risk factor. This video explores the confusion surrounding statins and Lp(a)…
Pemafibrate's Impact on Cardiovascular Risk in Diabetes Patients
This video discusses pemafibrate, a drug that lowers high triglyceride levels and improves lipids. A trial with nearly 10,500 patients showed that while it significantly reduced triglycerides, it did not lead to fewer…
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | JACC https://t.co/Sxf4FuPNhy
⏩ Lp(a)の動脈硬化リスク . Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | JACC https://t.co/0AVfhmdwi7
@nntaleb https://t.co/QiZPdjP4yY
https://t.co/YbxQq2lFHS
@jmwhit72 @DudzLightLime Hmm...if you believe that Lp(a), per particle is 6.6x as atherogenic than a run-of-the-mill LDL-p, I think you'd have a hard time justifying that approach... https://t.co/vqqz1i9U5X
RT @MAROSFO: Todo esto, entre otras cosas, hace que la #Lpa tenga un carácter más aterogénico, hasta 6 veces más que el LDL, adelante la en…
Todo esto, entre otras cosas, hace que la #Lpa tenga un carácter más aterogénico, hasta 6 veces más que el LDL, adelante la enfermedad cardiovascular y progrese más rápido @ArmandoOterino
RT @ZHeart11768530: Which is more atherogenic
We conclude that the atherogenicity of Lp(a) (CHD risk quotient per unit increase in particle number) is substantially greater than that of LDL. Therefore, Lp(a) represents a key target for drug-based intervention https://t.co/rdb1lUOb5i
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/2k6Ofrjp5v
RT @syaddana_neuro: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the Ameri…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @syaddana_neuro: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the Ameri…
RT @syaddana_neuro: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the Ameri…
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College of Cardiology. Why we shouldn’t be satisfied with just LDL targets !! @StrokeAHA_ASA https://t.co/2dyuUKvjE8
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/PzmHi0isJh
https://t.co/PzmHi0isJh
Access here https://t.co/yPwbXV2j1n
RT @hillypaige2: #KnowLpa #UniversalTesting 6x more atherogenic!
RT @hillypaige2: #KnowLpa #UniversalTesting 6x more atherogenic!
RT @hillypaige2: #KnowLpa #UniversalTesting 6x more atherogenic!
#KnowLpa #UniversalTesting 6x more atherogenic!
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
https://t.co/EE3YSPwIW5
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | SOMEONE SOMEWHERE (https://t.co/JnxfQijLjy)
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
RT @agingdoc1: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs ht…
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/x2BYEH2ZDs https://t.co/NEOwim2WrX
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College of Cardiology https://t.co/h6kPC3JSNE
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis https://t.co/9GKNvceBlS @JACCJournals
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
RT @DrMarthaGulati: Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone…
Really this original research in @JACCJournals which demonstrates Lp(a) being more atherogebic than LDL ❓Is everyone now assessing Lp(a) in our patients????? @VietHeartPA @ASPCardio @CBallantyneMD @TheFHFoundation @rblument1 @DrM_ODonoghue
Interested in more details? Link to full paper: https://t.co/wK3hF3zqXZ.
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @DrJJJavier: Lipoprotein(a) Is mas aterogenica que el LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College…
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
Lipoprotein(a) Is mas aterogenica que el LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College of Cardiology https://t.co/I3z02V74ES
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
RT @KagawaECG: ☑️ Lp(a)について Lp(a)「える・ぴー・りとるえー」は動脈硬化の原因で 1分子あたりの催動脈硬化作用はLDLの6倍程度
RT @ZHeart11768530: Which is more atherogenic
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
RT @KagawaECG: ☑️ Lp(a)について Lp(a)「える・ぴー・りとるえー」は動脈硬化の原因で 1分子あたりの催動脈硬化作用はLDLの6倍程度
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
☑️ Lp(a)について Lp(a)「える・ぴー・りとるえー」は動脈硬化の原因で 1分子あたりの催動脈硬化作用はLDLの6倍程度
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
RT @JACCJournals: Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was…
RT @JACCJournals: Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was…
RT @ZHeart11768530: Which is more atherogenic
RT @JACCJournals: Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was…
RT @CMichaelGibson: On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Geneti…
On a per particle basis, Lipoprotein(a) or Lp(a) is 6 times More atherogenic than LDL: An Apolipoprotein B-Based Genetic Analysis Do you know your Lp(a)? I do ... https://t.co/E2TVwcWRK0
RT @JACCJournals: Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was…
RT @ZHeart11768530: Which is more atherogenic
RT @JACCJournals: Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was…
RT @ZHeart11768530: Which is more atherogenic
RT @JACCJournals: Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was…
Which is more atherogenic
Using a genetic approach, this study tested the relative atherogenicity of Lp(a) & LDL particles & showed that Lp(a) was roughly 6 times more atherogenic than LDL per particle. Read more from this important work: https://t.co/Y2GCIX4Fqf #JACC #cvPrev @stevesphd @EliasBjornson https://t.co/VC5bB4mUY3
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College of Cardiology https://t.co/4MTftgLTti
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @stevesphd: New paper at @JACCJournals led by @EliasBjornson: "Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B…
https://t.co/WKjljLeFyh
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @acorderofort: Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the America…
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
RT @mgeorgakis1: Very elegant Mendelian randomization study @JACCJournals by @EliasBjornson et al:
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis | Journal of the American College of Cardiology https://t.co/MrTdRIDSN3 @MAROSFO @almucastro01 @lipidmir https://t.co/ASmUg7cLzE
Lipoprotein(a) is markedly more atherogenic Than LDL: An Apolipoprotein B-based genetic analysis https://t.co/XUz5p6cZDa #prevention #risk #LPa @kirstieclutton via @JACCJournals https://t.co/Tvv0wzX6RK
RT @stevesphd: New paper at @JACCJournals led by @EliasBjornson: "Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B…
RT @stevesphd: New paper at @JACCJournals led by @EliasBjornson: "Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B…
New paper at @JACCJournals led by @EliasBjornson: "Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B-based genetic analysis" - https://t.co/6LG6yYbDgw. Headline result: per apoB particle, Lp(a) is around 5-8 times more atherogenic than LDL. Brief thread: